EPCAM and hepatocellular carcinoma: Among the markers being investigated, GEP+ cells were shown to preferentially co-express with β-catenin, Oct4, Nanog, Sox2, CD133 and EpCAM when compared with GEP- cells in both HCC cell lines Hep3B (Figure S3) and Huh7 (Figure S4).